您要查找的是不是：
- Sirolimus is a kind of macrolide antibiotics as well as immunosuppressant. 西羅莫司是一種大環(huán)內酯類(lèi)抗生素,為一種免疫抑制劑。
- Disaccharides are glycosides in which the aglycon is a monosaccharide unit. 雙糖的糖苷配基是一個(gè)單糖單元的苷。
- Objective To evaluate the effects of six macrolide antibiotics against mycobacteria. 目的研究大環(huán)內酯類(lèi)抗生素抗分枝桿菌的作用。
- Spinosyns are novel macrolide insecticides produced by fermentation of Saccharopolyspora spinosa. 多殺菌素是刺糖多孢菌發(fā)酵產(chǎn)生的新型大環(huán)內酯類(lèi)殺蟲(chóng)抗生素。
- Objective: To study the macrolide antibiotic adverse reaction and safety of drug application. 目的:探討大環(huán)內酯類(lèi)抗生素的不良反應及用藥安全性。
- This paper introduces the characterization and application of a new polyene macrolide antirnycotics-Natamycin. 介紹了納他霉素作為新一代天然生物防腐劑的特性、作用機理、安全性等。
- The MS showed that this saponin has two glycosides, the m/z of aglycon is 491 and the molecular weight is 815. 進(jìn)一步用質(zhì)譜對其分子結構進(jìn)行初步推斷，這種皂甙是一個(gè)連有2個(gè)糖基的母核荷質(zhì)比為491、相對分子質(zhì)量為815的皂甙。
- OBJECTIVE: To evaluate the effect of macrolide antibiotics on community-acquired pneumonia(CAP). 目的:評價(jià)大環(huán)內酯類(lèi)抗生素在社區獲得性肺炎(CAP)治療中的作用。
- The study of gene engineering of macrolide antibiotics have made the rapid and exciting progress. 大環(huán)內酯類(lèi)抗生素的基因工程研究進(jìn)展十分迅速。
- Do not use is case of hypersensitivity of the target animals to macrolide antibiotics. 不能用于對大環(huán)酯物抗生素過(guò)敏的動(dòng)物。
- Polaramycin A and B are a new group of polyol macrolide antibiotics which includes 36 loops. 波拉霉素是一種新發(fā)現的多羥基大環(huán)內酯類(lèi)抗生素，該抗生素具有廣譜抗微生物活性。
- By orthogonal test,the optimum conditions for soybean isoflavone glycoside to be hydrolyzed into isoflavone aglycon were found. 通過(guò)正交試驗得到了大豆異黃酮糖苷水解為大豆異黃酮苷元的最佳工藝條件。
- Isoflavones are the main active components in kudzu root.Most of them exist in the form of isoflavone glycosides.The free aglycons are more active than their glycoside. 葛根中的主要活性成分是異黃酮，大部分異黃酮是以糖苷的形式存在，而相應游離甙元的活性要比糖苷高得多。
- RESULTS &CONCLUSION: On the basis of local pathogens of CAP and epidemiological data of drug-resistance bacteria,macrolide antibiotics will be rat... 結果與結論:應根據當地CAP病原體及耐藥菌流行病學(xué)資料,合理選擇使用大環(huán)內酯類(lèi)抗生素。
- This paper introduces characteriza tion and application of Natamycin -a polyene macrolide antirnycotics pr oduced by some strains of Streptomyces. 介紹了鏈霉菌產(chǎn)生的多烯大環(huán)內酯類(lèi)抗真菌劑納他霉素的特性及其應用。
- Nucleoside mimetics with modified glycon and/or aglycon and their biological activity was described. And antiviralnucleosides was focused in particular. 本文簡(jiǎn)述了核苷的種類(lèi)及其生物活性。根據分子結構的不同,對現有核苷作了分類(lèi)、歸納,展望了核苷類(lèi)藥物的研究方向。
- Conclusion Macrolide antibiotics are selection drugs in the treatment of nontuberculosis mycobacterial diseases clinically. 結論大環(huán)內酯類(lèi)抗生素是臨床非結核分枝桿菌病治療可選擇的藥物。
- Objective To evaluate the efficacy of macrolide antibiotics chloramphenicol and deoxycycline on the treatment of scrub typhus. 目的研究大環(huán)內酯類(lèi)抗生素與氯霉素和強力霉素治療恙蟲(chóng)病的療效區別。
- In addition to their regular asthma therapy, participants received a macrolide antibiotic (called klacid) or placebo medication for eight weeks. 除了常規的哮喘治療以外，這些哮喘患者還接受了持續8周大環(huán)內酯類(lèi)抗生素或安慰劑的治療。
- Methods Minimal inhibitory concentration(MIC)of six macrolide antibiotics against 20 mycobacteria species in vitro were determined. 方法分別測定6種大環(huán)內酯類(lèi)抗生素對20種分枝桿菌(包括結核、牛分枝桿菌和18種非結核分枝桿菌)的試管內最低抑菌濃度。
